BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 12417741)

  • 21. MBD4 loss results in global reactivation of promoters and retroelements with low methylated CpG density.
    Papin C; Ibrahim A; Sabir JSM; Le Gras S; Stoll I; Albiheyri RS; Zari AT; Bahieldin A; Bellacosa A; Bronner C; Hamiche A
    J Exp Clin Cancer Res; 2023 Nov; 42(1):301. PubMed ID: 37957685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites.
    Hendrich B; Hardeland U; Ng HH; Jiricny J; Bird A
    Nature; 1999 Sep; 401(6750):301-4. PubMed ID: 10499592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MBD4 Facilitates Immunoglobulin Class Switch Recombination.
    Grigera F; Wuerffel R; Kenter AL
    Mol Cell Biol; 2017 Jan; 37(2):. PubMed ID: 27777312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complex relationship between mismatch repair proteins and MBD4 during immunoglobulin class switch recombination.
    Grigera F; Bellacosa A; Kenter AL
    PLoS One; 2013; 8(10):e78370. PubMed ID: 24205214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nontruncating APC germ-line mutations and mismatch repair deficiency play a minor role in APC mutation-negative polyposis.
    Heinimann K; Thompson A; Locher A; Furlanetto T; Bader E; Wolf A; Meier R; Walter K; Bauerfeind P; Marra G; Müller H; Foernzler D; Dobbie Z
    Cancer Res; 2001 Oct; 61(20):7616-22. PubMed ID: 11606402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers.
    Goodfellow PJ; Buttin BM; Herzog TJ; Rader JS; Gibb RK; Swisher E; Look K; Walls KC; Fan MY; Mutch DG
    Proc Natl Acad Sci U S A; 2003 May; 100(10):5908-13. PubMed ID: 12732731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The identification of a novel alternatively spliced form of the MBD4 DNA glycosylase.
    Owen RM; Baker RD; Bader S; Dunlop MG; Nicholl ID
    Oncol Rep; 2007 Jan; 17(1):111-6. PubMed ID: 17143486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperplastic polyposis syndrome: phenotypic presentations and the role of MBD4 and MYH.
    Chow E; Lipton L; Lynch E; D'Souza R; Aragona C; Hodgkin L; Brown G; Winship I; Barker M; Buchanan D; Cowie S; Nasioulas S; du Sart D; Young J; Leggett B; Jass J; Macrae F
    Gastroenterology; 2006 Jul; 131(1):30-9. PubMed ID: 16831587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fas-associated death domain protein interacts with methyl-CpG binding domain protein 4: a potential link between genome surveillance and apoptosis.
    Screaton RA; Kiessling S; Sansom OJ; Millar CB; Maddison K; Bird A; Clarke AR; Frisch SM
    Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5211-6. PubMed ID: 12702765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glu346Lys polymorphism in the methyl-CpG binding domain 4 gene and the risk of primary lung cancer.
    Shin MC; Lee SJ; Choi JE; Cha SI; Kim CH; Lee WK; Kam S; Kang YM; Jung TH; Park JY
    Jpn J Clin Oncol; 2006 Aug; 36(8):483-8. PubMed ID: 16803845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of coding microsatellite frameshift mutations in DNA mismatch repair-deficient mouse intestinal tumors.
    Woerner SM; Tosti E; Yuan YP; Kloor M; Bork P; Edelmann W; Gebert J
    Mol Carcinog; 2015 Nov; 54(11):1376-86. PubMed ID: 25213383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutation in the mismatch repair gene Msh6 causes cancer susceptibility.
    Edelmann W; Yang K; Umar A; Heyer J; Lau K; Fan K; Liedtke W; Cohen PE; Kane MF; Lipford JR; Yu N; Crouse GF; Pollard JW; Kunkel T; Lipkin M; Kolodner R; Kucherlapati R
    Cell; 1997 Nov; 91(4):467-77. PubMed ID: 9390556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inter-individual variation in nucleotide excision repair pathway is modulated by non-synonymous polymorphisms in ERCC4 and MBD4 genes.
    Allione A; Guarrera S; Russo A; Ricceri F; Purohit R; Pagnani A; Rosa F; Polidoro S; Voglino F; Matullo G
    Mutat Res; 2013; 751-752():49-54. PubMed ID: 24004570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Structure basis of versatile base recognition of MBD4].
    Ariyoshi M; Otani J; Shirakawa M
    Yakugaku Zasshi; 2015; 135(1):3-9. PubMed ID: 25743892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The base excision repair enzyme MED1 mediates DNA damage response to antitumor drugs and is associated with mismatch repair system integrity.
    Cortellino S; Turner D; Masciullo V; Schepis F; Albino D; Daniel R; Skalka AM; Meropol NJ; Alberti C; Larue L; Bellacosa A
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15071-6. PubMed ID: 14614141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis.
    Reitmair AH; Cai JC; Bjerknes M; Redston M; Cheng H; Pind MT; Hay K; Mitri A; Bapat BV; Mak TW; Gallinger S
    Cancer Res; 1996 Jul; 56(13):2922-6. PubMed ID: 8674041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biphasic kinetics of the human DNA repair protein MED1 (MBD4), a mismatch-specific DNA N-glycosylase.
    Petronzelli F; Riccio A; Markham GD; Seeholzer SH; Stoerker J; Genuardi M; Yeung AT; Matsumoto Y; Bellacosa A
    J Biol Chem; 2000 Oct; 275(42):32422-9. PubMed ID: 10930409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MBD4 and TDG: multifaceted DNA glycosylases with ever expanding biological roles.
    Sjolund AB; Senejani AG; Sweasy JB
    Mutat Res; 2013; 743-744():12-25. PubMed ID: 23195996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Germline MBD4 deficiency causes a multi-tumor predisposition syndrome.
    Palles C; West HD; Chew E; Galavotti S; Flensburg C; Grolleman JE; Jansen EAM; Curley H; Chegwidden L; Arbe-Barnes EH; Lander N; Truscott R; Pagan J; Bajel A; Sherwood K; Martin L; Thomas H; Georgiou D; Fostira F; Goldberg Y; Adams DJ; van der Biezen SAM; Christie M; Clendenning M; Thomas LE; Deltas C; Dimovski AJ; Dymerska D; Lubinski J; Mahmood K; van der Post RS; Sanders M; Weitz J; Taylor JC; Turnbull C; Vreede L; van Wezel T; Whalley C; Arnedo-Pac C; Caravagna G; Cross W; Chubb D; Frangou A; Gruber AJ; Kinnersley B; Noyvert B; Church D; Graham T; Houlston R; Lopez-Bigas N; Sottoriva A; Wedge D; ; ; ; Jenkins MA; Kuiper RP; Roberts AW; Cheadle JP; Ligtenberg MJL; Hoogerbrugge N; Koelzer VH; Rivas AD; Winship IM; Ponte CR; Buchanan DD; Power DG; Green A; Tomlinson IPM; Sampson JR; Majewski IJ; de Voer RM
    Am J Hum Genet; 2022 May; 109(5):953-960. PubMed ID: 35460607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic downregulation of the DNA repair gene MED1/MBD4 in colorectal and ovarian cancer.
    Howard JH; Frolov A; Tzeng CW; Stewart A; Midzak A; Majmundar A; Godwin A; Heslin M; Bellacosa A; Arnoletti JP
    Cancer Biol Ther; 2009 Jan; 8(1):94-100. PubMed ID: 19127118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.